Home > Healthcare > Biotechnology > Bioservices > Spatial Genomics and Transcriptomics Market

Spatial Genomics and Transcriptomics Market Size

Report ID: GMI5968
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Spatial Genomics and Transcriptomics Market Size

Spatial Genomics and Transcriptomics Market size was estimated at USD 305.7 million in 2022 and is projected to increase at a CAGR of 15.2% from 2023 to 2032. The market is driven by the various factors such as increasing demand for new technologies that can be used to study the spatial organization genome, increasing research focus on spatial biology, growing demand for deeper insights into cellular function and organization, and advances in sequencing technologies.

To get key market trends

Download Free Sample

Spatial genomics and transcriptomics allow for the integration of multi-omics data, including genomics, transcriptomics, proteomics, and epigenomics. By combining different layers of molecular information with spatial context, researchers can gain a more comprehensive understanding of biological processes and cellular interactions. The demand for integrated multi-omics approaches has contributed to the market growth.

Spatial Genomics and Transcriptomics Market Report Attributes
Report Attribute	Details
Base Year:	2022
Spatial Genomics and Transcriptomics Market Size in 2022:	USD 305.7 Million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	15.2%
2032 Value Projection:	USD 1.2 Billion
Historical Data for:	2018 to 2022
No. of Pages:	364
Tables, Charts & Figures:	620
Segments covered:	Technique, Product, Application, End-user, and Region
Growth Drivers:	Increasing R&D investment in genomics and transcriptomics Advances in sequencing technologies Increasing adoption of spatial genomics & transcriptomics in drug discovery Increasing adoption of personalized medicine
Pitfalls & Challenges:	Lack of standardized protocols High cost of technology

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for spatial genomics and transcriptomics was worth over USD 305.5 million in 2022 and is projected to record over 15% CAGR through 2032, owing to increasing research focus on spatial biology, growing demand for deeper insights into cellular function & organization, and advances in sequencing technologies.

The translational research segment will grow at more than 18% CAGR between 2023 to 2032, as the application aims to bridge the gap between basic research discoveries and their practicality in clinical settings. Translation research highlights the potential clinical relevance and utility of spatial genomics and transcriptomics technologies.

North America spatial genomics and transcriptomics market will register a growth rate of over 15% during 2023-2032, on account of a robust R&D landscape in the region, along with a high concentration of pharmaceutical & biotechnology companies, academic institutions, and research organizations.

Natera Inc., 10x Genomics, Dovetail Genomics, Illumina, Inc., S2 Genomics, Inc., NanoString Technologies, Inc., Seven Bridges Genomics, Horizon Discovery Group plc, CARTANA AB, READCOOR, INC., Bio-Techne Corporation, and Bio-Rad Laboratories, Inc. among others.